{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:04:04Z","timestamp":1789470244969,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate detection of macroscopic residual disease after neuroblastoma resection is essential for postoperative treatment decisions, including radiotherapy. Standard imaging follow-up is often performed at a time point when postoperative and therapy-related changes may hamper reliable differentiation between residual disease and reactive findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess inter-reader agreement and the diagnostic accuracy of early postoperative magnetic resonance imaging (MRI) for detecting residual disease after neuroblastoma surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included patients with histologically confirmed neuroblastic tumors who underwent surgical resection at a reference center and received standardized early postoperative MRI with adequate preoperative imaging. Two independent pediatric radiologists, blinded to all clinical data, assessed all examinations. A hierarchical multimodal reference standard was established based on surgical reports including expert consensus between a senior pediatric radiologist and a pediatric surgeon, and follow-up imaging (median follow-up 33\u00a0months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-nine patients (median age 46\u00a0months), predominantly with International Neuroblastoma Staging System (INSS) stage 4 neuroblastoma, were included; all patients had at least one image-defined risk factor. MRI was performed at a mean of 8\u00b15\u00a0days after surgery. Residual disease was identified in 14 patients and confirmed by the reference standard. Five residual diseases were expected by the surgeons (median volume 8\u00a0ml), whereas nine were unexpected and small (median volume 1\u00a0ml). Diagnostic accuracy were 95% and 90% for the two readers, respectively, with substantial inter-reader agreement (Cohen\u2019s\n                      <jats:italic>\u03ba<\/jats:italic>\n                      =0.76). Early postoperative MRI findings led to clinically relevant management adaptations in selected cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early postoperative MRI demonstrates high diagnostic accuracy and substantial inter-reader agreement in detecting macroscopic residual disease, providing a robust baseline for further assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00247-026-06672-5","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:22:28Z","timestamp":1779942148000},"page":"2283-2291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inter-reader agreement and diagnostic accuracy of early postoperative magnetic resonance imaging for detecting macroscopic residual disease in neuroblastic tumors"],"prefix":"10.1007","volume":"56","author":[{"given":"Marianna","family":"Chaika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Urla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Warmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Spogis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Krumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Borkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen F.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"6672_CR1","doi-asserted-by":"crossref","unstructured":"Avanzini S, Pio L, Erminio G et al (2017)\u00a0Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer 64","DOI":"10.1002\/pbc.26605"},{"key":"6672_CR2","doi-asserted-by":"crossref","unstructured":"Yu AL, Gilman AL, Ozkaynak MF et al (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363:1324\u20131334","DOI":"10.1056\/NEJMoa0911123"},{"key":"6672_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.706800","volume":"9","author":"Y Qi","year":"2021","unstructured":"Qi Y, Zhan J (2021) Roles of surgery in the treatment of patients with high-risk neuroblastoma in the Children Oncology Group study: a systematic review and meta-analysis. Front Pediatr 9:706800","journal-title":"Front Pediatr"},{"key":"6672_CR4","doi-asserted-by":"crossref","unstructured":"Fischer J, Pohl A, Volland R et al (2017) Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer 17:520","DOI":"10.1186\/s12885-017-3493-0"},{"key":"6672_CR5","doi-asserted-by":"crossref","unstructured":"Seemann NM, Erker C, Irwin MS et al (2023)\u00a0Survival effect of complete surgical resection of the primary tumor inpatients with metastatic, high-risk neuroblastoma in a large Canadian cohort. Pediatr Blood Cancer 70","DOI":"10.1002\/pbc.30286"},{"key":"6672_CR6","doi-asserted-by":"crossref","unstructured":"Bradfield SM, Douglas JG, Hawkins DS et al (2004) Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma. Cancer 100:1268\u20131275","DOI":"10.1002\/cncr.20091"},{"key":"6672_CR7","doi-asserted-by":"crossref","unstructured":"Gatcombe HG, Marcus RB Jr., Katzenstein HM et al (2009) Excellent local control from radiation therapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 74:1549\u20131554","DOI":"10.1016\/j.ijrobp.2008.10.069"},{"key":"6672_CR8","doi-asserted-by":"crossref","unstructured":"Liu KX, Naranjo A, Zhang FF et al (2020) Prospective evaluation of radiation dose escalation in patients with high-risk neuroblastoma and gross residual disease after surgery: a report from the Children\u2019s Oncology Group ANBL0532 Study. J Clin Oncol 38:2741\u20132752","DOI":"10.1200\/JCO.19.03316"},{"key":"6672_CR9","doi-asserted-by":"crossref","unstructured":"Zhao Q, Liu Y, Zhang Y et al (2020) Role and toxicity of radiation therapy in neuroblastoma patients: a literature review. Crit Rev Oncol Hematol 149:102924","DOI":"10.1016\/j.critrevonc.2020.102924"},{"key":"6672_CR10","doi-asserted-by":"crossref","unstructured":"von Allmen D, Davidoff AM, London WB et al (2017) Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol 35:208\u2013216","DOI":"10.1200\/JCO.2016.67.2642"},{"key":"6672_CR11","doi-asserted-by":"crossref","unstructured":"Kamp MA, Rapp M, Buhner J et al (2015) Early postoperative magnetic resonance tomography after resection of cerebral metastases. Acta Neurochir (Wien) 157:1573\u20131580","DOI":"10.1007\/s00701-015-2479-4"},{"key":"6672_CR12","doi-asserted-by":"crossref","unstructured":"Jazmati D, Brualla L, Littooij AS et al (2023) Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee. Radiother Oncol 181:109464","DOI":"10.1016\/j.radonc.2023.109464"},{"key":"6672_CR13","doi-asserted-by":"crossref","unstructured":"Sarioglu FC, Salman M, Guleryuz H et al (2019) Radiological staging in neuroblastoma: computed tomography or magnetic resonance imaging? Pol J Radiol 84:e46\u2013e53","DOI":"10.5114\/pjr.2019.82736"},{"key":"6672_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00247-018-4117-9","volume":"48","author":"AM Chen","year":"2018","unstructured":"Chen AM, Trout AT, Towbin AJ (2018) A review of neuroblastoma image-defined risk factors on magnetic resonance imaging. Pediatr Radiol 48:1337\u20131347","journal-title":"Pediatr Radiol"},{"key":"6672_CR15","doi-asserted-by":"crossref","unstructured":"Schafer JF, Gassenmaier S, Warmann S et al (2023)\u00a0Local MRI before and after tumor resection in neuroblastoma: impact of residual disease on event free survival. J Clin Med 12:2338","DOI":"10.3390\/jcm12237297"},{"key":"6672_CR16","doi-asserted-by":"crossref","unstructured":"Holmes K, Potschger U, Pearson ADJ et al (2020) Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma: a report from the HR-NBL1\/SIOPEN Study. J Clin Oncol 38:2902\u20132915","DOI":"10.1200\/JCO.19.03117"},{"key":"6672_CR17","doi-asserted-by":"crossref","unstructured":"La Quaglia MP, Kushner BH, Su W et al (2004) The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 39:412\u2013417 discussion 412\u2013417","DOI":"10.1016\/j.jpedsurg.2003.11.028"},{"key":"6672_CR18","doi-asserted-by":"crossref","unstructured":"Park JR, Bagatell R, Cohn SL et al (2017) Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 35:2580\u20132587","DOI":"10.1200\/JCO.2016.72.0177"},{"key":"6672_CR19","doi-asserted-by":"crossref","unstructured":"Gahr N, Darge K, Hahn G et al (2011) Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma\/ganglioneuroma. Eur J Radiol 79:443\u2013446","DOI":"10.1016\/j.ejrad.2010.04.005"},{"key":"6672_CR20","doi-asserted-by":"crossref","unstructured":"Gassenmaier S, Tsiflikas I, Fuchs J et al (2020) Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors. Cancer Imaging 20:89","DOI":"10.1186\/s40644-020-00366-3"},{"key":"6672_CR21","doi-asserted-by":"crossref","unstructured":"Neubauer H, Li M, Muller VR et al (2017) Diagnostic value of diffusion-weighted MRI for tumor characterization, differentiation and monitoring in pediatric patients with neuroblastic tumors. Rofo 189:640\u2013650","DOI":"10.1055\/s-0043-108993"},{"key":"6672_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00247-022-05489-2","volume":"53","author":"AS Littooij","year":"2023","unstructured":"Littooij AS, de Keizer B (2023) Imaging in neuroblastoma. Pediatr Radiol 53:783\u2013787","journal-title":"Pediatr Radiol"},{"key":"6672_CR23","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00247-018-4162-4","volume":"48","author":"SD Voss","year":"2018","unstructured":"Voss SD (2018) Staging and following common pediatric malignancies: MRI versus CT versus functional imaging. Pediatr Radiol 48:1324\u20131336","journal-title":"Pediatr Radiol"},{"key":"6672_CR24","doi-asserted-by":"crossref","unstructured":"Gassenmaier S, Tsiflikas I, Maennlin S et al (2020) Retrospective accuracy analysis of MRI based lesion size measurement in neuroblastic tumors: which sequence should we choose? BMC Med Imaging 20:105","DOI":"10.1186\/s12880-020-00503-1"},{"key":"6672_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4103\/0971-3026.169466","volume":"25","author":"BB Thukral","year":"2015","unstructured":"Thukral BB (2015) Problems and preferences in pediatric imaging. Indian J Radiol Imaging 25:359\u2013364","journal-title":"Indian J Radiol Imaging"},{"key":"6672_CR26","doi-asserted-by":"crossref","unstructured":"Zwaveling S, Tytgat GA, van der Zee DC et al (2012) Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice? Pediatr Surg Int 28:953\u2013959","DOI":"10.1007\/s00383-012-3109-3"},{"key":"6672_CR27","doi-asserted-by":"crossref","unstructured":"Simon T, H\u00e4berle B, Hero B et al (2013) Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol 31:752\u2013758","DOI":"10.1200\/JCO.2012.45.9339"},{"key":"6672_CR28","doi-asserted-by":"crossref","unstructured":"Simon T, Thole T, Castelli S et al (2025) GPOH guidelines for diagnosis and first-line treatment of patients with neuroblastic tumors, update 2025. Klin Padiatr 237:117\u2013140","DOI":"10.1055\/a-2556-4302"},{"key":"6672_CR29","doi-asserted-by":"crossref","unstructured":"Wolden SL, Gollamudi SV, Kushner BH et al (2000) Local control with multimodality therapy for stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys 46:969\u2013974","DOI":"10.1016\/S0360-3016(99)00399-5"},{"key":"6672_CR30","doi-asserted-by":"crossref","unstructured":"Ferris MJ, Danish H, Switchenko JM et al (2017) Favorable local control from consolidative radiation therapy in high-risk neuroblastoma despite gross residual disease, positive margins, or nodal involvement. Int J Radiat Oncol Biol Phys 97:806\u2013812","DOI":"10.1016\/j.ijrobp.2016.11.043"},{"key":"6672_CR31","doi-asserted-by":"crossref","unstructured":"Lucas JT Jr., McCarville MB, Cooper DA et al (2019) Implications of image-defined risk factors and primary-site response on local control and radiation treatment delivery in the management of high-risk neuroblastoma: is there a role for de-escalation of adjuvant primary-site radiation therapy? Int J Radiat Oncol Biol Phys 103:869\u2013877","DOI":"10.1016\/j.ijrobp.2018.11.041"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-026-06672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00247-026-06672-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-026-06672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:17:46Z","timestamp":1789467466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00247-026-06672-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6672"],"URL":"https:\/\/doi.org\/10.1007\/s00247-026-06672-5","relation":{},"ISSN":["1432-1998"],"issn-type":[{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}